Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03755401 · ClinicalTrials.gov registry record · NA
Post-Traumatic Stress Disorder Focused Psychodynamic Psychotherapy
A NA study of PTSD, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT03755401: Recruiting NA study of PTSD, sponsored by Montefiore Medical Center.
NCT03755401 is a NA study of PTSD that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 75 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03755401, a NA study of PTSD, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial of Trauma-Focused Psychodynamic Psychotherapy (TFPP) in comparison with TAU (at the VA) in a 2:1 ratio in 75 Veterans with PTSD who have not responded to standard treatment at the VA.
Primary Outcome
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). Low score indicates fewer PTSD symptoms, high score indicates more PTSD symptoms.
Conditions Studied
Interventions
- OTHER TFPP
- OTHER TAU
Study Locations (1)
New York
- VA New York Harbor Healthcare System - Manhattan Campus - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-11-02 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT03755401 shows while recruiting
NCT03755401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (75% lower).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which TFPP is the first listed.
NCT03755401 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03755401 about?
NCT03755401 is a clinical study titled "Post-Traumatic Stress Disorder Focused Psychodynamic Psychotherapy". This is a randomized controlled trial of Trauma-Focused Psychodynamic Psychotherapy (TFPP) in comparison with TAU (at the VA) in a 2:1 ratio in 75 Veterans with PTSD who have not responded to standard treatment at the VA.
What is the current status of trial NCT03755401?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2018-11-02. Estimated completion is 2027-05.
What conditions does trial NCT03755401 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT03755401?
The interventions under investigation include: TFPP (OTHER), TAU (OTHER).
Who is sponsoring clinical trial NCT03755401?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03755401 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03755401's enrollment target sits among peer trials
75 78th of 154 higher than 75 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI